KOPRI Repository

Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease

Cited 0 time in wos
Cited 0 time in scopus

Full metadata record

DC Field Value Language
dc.contributor.authorKim, Tai Kyoung-
dc.contributor.authorHong, Ju-Mi-
dc.contributor.authorKim, Kyung Hee-
dc.contributor.authorHan, Se Jong-
dc.contributor.authorKim, Il-Chan-
dc.contributor.authorOh, Hyuncheol-
dc.contributor.authorYim, Joung Han-
dc.date.accessioned2022-07-08T01:01:51Z-
dc.date.available2022-07-08T01:01:51Z-
dc.date.issued2021-11-
dc.identifier.urihttps://repository.kopri.re.kr/handle/201206/13634-
dc.description.abstractThe pathogenesis of Alzheimer's disease (AD) is still unclear, and presently, there is no cure for the disease that can be used for its treatment or to stop its progression. Here, we investigated the therapeutic potential of ramalin (isolated from the Antarctic lichen, Ramalina terebrata), which exhibits various physiological activities, in AD. Specifically, derivatives were synthesized based on the structure of ramalin, which has a strong antioxidant effect, BACE-1 inhibition activity and anti-inflammatory effects. Therefore, ramalin and its derivatives exhibit activity against multiple targets associated with AD, and can serve as potential therapeutic agents for the disease.en_US
dc.languageEnglishen_US
dc.language.isoenen_US
dc.subjectBiochemistry & Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subject.classificationKing Sejong Stationen_US
dc.titlePotential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Diseaseen_US
dc.title.alternative라말린 및 그 유도체들의 알츠하이머병 치료제로서의 잠재적 가능성en_US
dc.typeArticleen_US
dc.identifier.bibliographicCitationKim, Tai Kyoung, et al. 2021. "Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease". <em>MOLECULES</em>, 26(21): 1-12.-
dc.citation.titleMOLECULESen_US
dc.citation.volume26en_US
dc.citation.number21en_US
dc.identifier.doi10.3390/molecules26216445-
dc.citation.startPage1en_US
dc.citation.endPage12en_US
dc.description.articleClassificationSCIE-
dc.description.jcrRateJCR 2019:39.548en_US
dc.subject.keywordAlzheimer's diseaseen_US
dc.subject.keywordramalinen_US
dc.subject.keywordderivativesen_US
dc.subject.keywordtherapeutic potentialen_US
dc.subject.keywordantioxidanten_US
dc.subject.keywordbeta-secrataseen_US
dc.subject.keywordanti-inflammatoryen_US
dc.identifier.localId2021-0226-
dc.identifier.scopusid2-s2.0-85100983660-
dc.identifier.wosid000718478800001-
Appears in Collections  
2021-2021, Development of new Alzheimer's anti-dementia medicine using polar lichen-derived metabolites (21-21) / Yim, Joung Han (PM21010)
Files in This Item

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse